Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7150
+0.0450 (2.69%)
NASDAQ · Last Trade: Jan 11th, 8:10 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors